KNW Form 3: Goldeneye 1995 LLC Buys 357.8M Shares in Private Placement

Rhea-AI Filing Summary

On August 6, 2025 Know Labs issued 357,815,000 shares of common stock to Goldeneye 1995 LLC in a private placement at $0.335 per share, disclosed on an initial Form 3. The filing names Robert Gregory Kidd as sole owner and manager of the reporting entity and states he has voting control and investment discretion over the shares.

Positive

• Clear disclosure of a private placement: 357,815,000 shares at $0.335 per share.
• Identification of control: Robert Gregory Kidd is named as sole owner/manager with voting control and investment discretion.

Negative

• The filing does not state the issuer's total shares outstanding, so the ownership percentage and materiality to shareholders cannot be determined from this form.
• No additional terms of the private placement (such as related approvals or transfer restrictions) are disclosed in this Form 3.

Insights

Corporate Governance Expert

TL;DR: Director-affiliated entity received a large private-placement block; beneficiary control is clearly disclosed.

The Form 3 reports an issuer-led private placement on 08/06/2025 resulting in Goldeneye 1995 LLC holding 357,815,000 common shares at $0.335 per share. The filing appropriately identifies Robert Gregory Kidd as the sole owner/manager with voting control and investment discretion, which satisfies Section 16 beneficial ownership disclosure. The filing does not provide the issuer's total outstanding shares or percentage ownership, so governance implications cannot be sized from this form alone.

Securities Analyst

TL;DR: Large equity issuance to an affiliated investor disclosed; pricing and holder control are stated but ownership percentage is unknown.

Table I shows the direct ownership of 357,815,000 common shares by Goldeneye 1995 LLC resulting from a private placement. Table II lists no derivative securities. The filing documents the transaction price ($0.335 per share) and the reporting person's control status, but lacks context on total shares outstanding or dilution metrics, limiting assessment of market or valuation impact from this document alone.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Goldeneye 1995 LLC

(Last) (First) (Middle)

619 WESTERN AVENUE, SUITE 610

(Street)

SEATTLE WA 98104

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2025

3. Issuer Name and Ticker or Trading Symbol
KNOW LABS, INC. [ KNW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	357,815,000(1)	D(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 6, 2025, the Issuer and the Reporting Person closed on a private placement pursuant to which the Issuer issued 357,815,000 shares of common stock to the Reporting Person at a per share purchase price of $0.335.

2. Robert Gregory Kidd is the sole owner and manager of the Reporting Person. Mr. Kidd has voting control and investment discretion over the securities held by the Reporting Person. As such, Mr. Kidd may be deemed to be the beneficial owner of the securities held by the Reporting Person.

	/s/ Robert Gregory Kidd	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Know Labs' (KNW) Form 3 report?

The Form 3 reports a private placement on 08/06/2025 in which Know Labs issued 357,815,000 common shares to Goldeneye 1995 LLC at $0.335 per share.

Who is the reporting person on the Form 3 for KNW?

The reporting person is Goldeneye 1995 LLC. The form states Robert Gregory Kidd is the sole owner and manager with voting control and investment discretion.

What is the relationship between the reporting person and Know Labs (KNW)?

The filing indicates the reporting person is a Director of the issuer.

Were any derivative securities reported on the Form 3?

No. Table II lists no derivative securities; only common stock is reported in Table I.

When was the Form 3 signed?

The signature block shows the form was signed by Robert Gregory Kidd on 08/08/2025.